(Q40847872)

24 September 2017

title

p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivo (English)

1 reference

24 September 2017

Cardinali M

1

1 reference

24 September 2017

Jakus J

2

1 reference

24 September 2017

Shah S

3

1 reference

24 September 2017

Ensley JF

4

1 reference

24 September 2017

Robbins KC

5

1 reference

24 September 2017

Yeudall WA

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

24 September 2017

1 reference

24 September 2017

volume

34

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

211-218

1 reference

Checkpoints: controls that ensure the order of cell cycle events

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Cyclin kinase inhibitors add a new dimension to cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Inhibition of ras-induced proliferation and cellular transformation by p16INK4.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Growth arrest and suppression of tumorigenicity of bladder-carcinoma cell lines induced by the P16/CDKN2 (p16INK4A, MTS1) gene and other loci on human chromosome 9

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

p53: at the crossroads of molecular carcinogenesis and risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

TGF-beta receptor regulation mediates the response to exogenous ligand but is independent of the degree of cellular differentiation in human oral keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Computed Tomographic Density of Metastatic Lymph Nodes as a Treatment-Related Prognostic Factor in Advanced Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Correlation between nodal density in contrasted scans and response to cisplatin-based chemotherapy in head and neck squamous cell cancer: a prospective validation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21).

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Wild-type p53 can inhibit oncogene-mediated focus formation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

The p53 proto-oncogene can act as a suppressor of transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Thymocyte apoptosis induced by p53-dependent and independent pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

p53 is required for radiation-induced apoptosis in mouse thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

Adenovirus‐mediated gene transfer of wild‐type p53 results in melanoma cell apoptosis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

The clinical application of DNA content and kinetic parameters in the treatment of patients with squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2897%2900083-3

7 January 2021

10.1016/S1368-8375(97)00083-3

Identifiers

DOI

1 reference

24 September 2017

1 reference